Comerica, Inc (CMA) concluded trading on Thursday at a closing price of $67.36, with 3.5 million shares of worth about $235.71 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 25.41% during that period and on January 30, 2025 the price saw a gain of about 3.17%. Currently the company’s common shares owned by public are about 131.41M shares, out of which, 130.33M shares are available for trading.
Stock saw a price change of 7.72% in past 5 days and over the past one month there was a price change of 9.05%. Year-to-date (YTD), CMA shares are showing a performance of 8.91% which increased to 20.61% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $45.32 but also hit the highest price of $73.45 during that period. The average intraday trading volume for Comerica, Inc shares is 2.24 million. The stock is currently trading 6.25% above its 20-day simple moving average (SMA20), while that difference is up 2.65% for SMA50 and it goes to 16.30% higher than SMA200.
Comerica, Inc (NYSE: CMA) currently have 131.41M outstanding shares and institutions hold larger chunk of about 86.96% of that.
The stock has a current market capitalization of $8.86B and its 3Y-monthly beta is at 1.27. PE ratio of stock for trailing 12 months is 13.42, while it has posted earnings per share of $5.02 in the same period. Its PEG reads 1.51 while making debt-to-equity ratio of 1.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CMA, volatility over the week remained 3.39% while standing at 2.75% over the month.
Stock’s fiscal year EPS is expected to rise by 6.78% while it is estimated to increase by 10.93% in next year. EPS is likely to grow at an annualized rate of 8.90% for next 5-years, compared to annual growth of -8.64% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on January 07, 2025 offering a Neutral rating for the stock and assigned a target price of $71 to it. On November 15, 2024, Wells Fargo Upgrade their recommendations, while on October 07, 2024, BofA Securities Downgrade their ratings for the stock with a price target of $52. Stock get an Outperform rating from Wedbush on September 24, 2024.
